IDH1 and acute myeloid leukemia: For instance, bis-2-[5-9phenylacetamide)-1,3,4-thiadiazol-2y]ethyl sulfide (BPTES) has been shown to block glutaminase and thus hamper the glutamate metabolism and reduce proliferation and growth in IDH mutant AML cell [79,228].